LOS ANGELES, March 3, 2020 /PRNewswire/ -- Discovery Behavioral Health, an expanding nationwide provider of behavioral health services, has opened a new facility in San Jacinto, located in Riverside County in the Inland Empire metro area of Southern California. Discove

PRINCETON, N.J., March 3, 2020 /PRNewswire/ -- WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical trials, today announced that The Michael J. Fox Foundation for Parkinson's Research (MJFF) is introducing a redesigned version of its Fox Trial Finder clinical study matching tool powered by WCG CenterWatch iCon

NEW YORK, March 3, 2020 /PRNewswire/ -- Ride Health, coordinating smarter transportation for every patient need, announced that CEO and Founder Imran Cronk

SOUTH SAN FRANCISCO, Calif., March 3, 2020 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced that it has raised $100 million in a Series C financing. Pliant plans to use the proceeds from the financing

PLYMOUTH MEETING, Pa., March 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection the World Health Organization (WHO) has designated a Public Health Emergency of International Concern of the highest level. According to WHO, approxima

WESTBURY, N.Y., March 3, 2020 /PRNewswire/ -- BioIVT, a leading provider of research models and services for drug and diagnostic development, announced that it is now providing same-day delivery of fresh blood, LEUKOMAX® leukopaks and buffy coats from normal and disease-state donors to cell and gene therapy researchers in the UK. BioIVT is also shippi

BOSTON, March 3, 2020 /PRNewswire/ -- XRHealth, the leader in extended reality and therapeutic applications, today announced it will be providing virtual reality (VR) telehealth services to the Sheba

MONROE TOWNSHIP, N.J., March 3, 2020 /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, announces its commitment to achieve a colorectal cancer screening rate for its employees of at least 80%.

LEXINGTON, Mass., March 3, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, today announced it will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, March 12, 2020. Agenus executives will

BEDFORD, Mass., March 3, 2020 /PRNewswire/ -- Access Vascular, Inc. today announced it has received FDA clearance for the second generation of its